Drugs / L-alpha-acetylmethadol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00000356 | Jun 1991 → Aug 1992 | opiate dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-alpha-acetylmethadol | “The purpose of this study is to determine the pharmacokinetics of L-alpha-acetylmethadol (LAAM) in adults transferred from methadone maintenance treatment for opiate dependence.” NCT00000356 ↗ |
| Known as | LAAM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000356 ↗ |